WaferGen Bio-systems, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$39.9M

433 transactions

Summary

WaferGen Bio-systems, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $5.9MSales: $2.5M23 insiders

Date	Insider	Type	Value
2017-02-28	Carlson Rolland(CEO and President)	D	$368K
2017-02-28	KANTER JOEL S	D	$63K
2017-02-28	Hautamaki R Dean	D	$63K
2017-02-28	Kaneshiro Makoto	D	$62K
2017-02-28	McKenzie William Douglas	D	$62K
2017-02-28	Schueren Robert Alan	D	$62K
2017-02-28	Henighan Michael P(Chief Financial Officer)	D	$29K
2017-02-28	KANTER JOEL S	D	—
2017-02-28	TRIFUNOVICH IVAN	D	—
2017-02-28	Carlson Rolland(CEO and President)	D	$0
2017-02-28	Henighan Michael P(Chief Financial Officer)	D	—
2017-01-03	Hautamaki R Dean	A	$0
2017-01-03	Kaneshiro Makoto	A	$0
2017-01-03	KANTER JOEL S	A	$0
2017-01-03	McKenzie William Douglas	A	$0
2017-01-03	Schueren Robert Alan	A	$0
2016-01-22	TRIFUNOVICH IVAN	A	$0
2016-01-22	Henighan Michael P(Chief Financial Officer)	A	$0
2016-01-04	Hautamaki R Dean	A	$0
2016-01-04	Kaneshiro Makoto	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

WaferGen Bio-systems, Inc. — Contributions, Lobbying & Contracts | Poliscope